Addressing the innovation gap

Drug News and Perspectives

Volumn 20, Issue 4, 2007, Pages 265-269

  Jeffrey, Phillip ^a,b   Warne, Peter ^a   Williams, Robert ^a,c  

^a Biointerface ^*

^b GLAXOSMITHKLINE   (United Kingdom)

^c Cancer Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ANTIOBESITY AGENT; CETILISTAT; DONEPEZIL; DOXAZOSIN; LEUPEPTIN; PREDNISOLONE 3 SULFOBENZOATE; SILDENAFIL; SUNITINIB; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CANCER; CLINICAL TRIAL; CONFERENCE PAPER; DRUG APPROVAL; DRUG COST; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG MARKETING; GASTROINTESTINAL DISEASE; HUMAN; HUMAN GENOME; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MUSCULAR DYSTROPHY; OBESITY; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

DIFFUSION OF INNOVATION; EPITOPES; INFORMATICS; PHARMACOLOGY;

EID: 34547770393     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Harper, G., Pickett, S.D., Green, D.V. Design of a compound screening collection for use in high throughput screening. Comb Chem High Throughput Screen 2004, 7(1): 63-70.